F.D.A. Panel Recommends Pfizer Boosters for Over 65 or at High Risk of Severe Covid
The same advisers overwhelmingly recommended against authorizing boosters for people under 65, complicating the Biden administration ’s hopes to offer them more broadly.
Source: NYT Health - Category: Consumer Health News Authors: Noah Weiland and Sharon LaFraniere Tags: Vaccination and Immunization Coronavirus (2019-nCoV) Food and Drug Administration Pfizer Inc BioNTech SE United States Source Type: news
More News: Coronavirus | COVID-19 | Food and Drug Administration (FDA) | Health | Pfizer | USA Health | Vaccines